Aphria (NYSE: APHA) was easily the best-performing Canadian marijuana stock among the top five licensed producers last year. Nonetheless, the company's stock was still a big loser in absolute terms, with its shares falling by over 8% over the course of 2019. That fact speaks volumes about just how poorly the other big names in the industry. like Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), Cronos Group (NASDAQ: CRON), and Tilray, performed in 2019. In fact, it was arguably the steady stream of underwhelming earnings reports from these other big marijuana players that caused Aphria's shares to drastically underperform the broader markets last year. Aphria, after all, actually posted two consecutive profitable quarters in calendar year 2019 -- a feat no other top Canadian cultivator accomplished.
Should investors take advantage of Aphria's year-long weakness right now, or is it best to watch this top marijuana stock from the safety of the sidelines in 2020? Let's take a deeper look at Aphria's potential risks and rewards to find out.
Image source: Getty Images.